康众医疗8月26日获融资买入1054.73万元，融资余额1.66亿元

Group 1 - The core viewpoint of the news is that 康众医疗 (Kangzhong Medical) is experiencing fluctuations in its stock performance and financing activities, with a notable decrease in net profit despite revenue growth [1][2]. - On August 26, 康众医疗's stock price fell by 0.10%, with a trading volume of 88.46 million yuan. The financing buy-in amount was 10.55 million yuan, while the financing repayment was 13.86 million yuan, resulting in a net financing buy-in of -3.31 million yuan [1]. - As of August 26, the total balance of margin trading for 康众医疗 was 166 million yuan, accounting for 6.42% of its market capitalization, indicating a high level of financing activity compared to the past year [1]. Group 2 - As of June 30, 康众医疗 had 4,760 shareholders, an increase of 0.74% from the previous period, while the average number of circulating shares per person decreased by 0.74% to 18,514 shares [2]. - For the first half of 2025, 康众医疗 reported a revenue of 145 million yuan, representing a year-on-year growth of 12.41%. However, the net profit attributable to the parent company was -739,400 yuan, a decrease of 110.10% compared to the previous year [2]. - 康众医疗 has distributed a total of 65.57 million yuan in dividends since its A-share listing, with 10.05 million yuan distributed over the past three years [3].